USD 0.47
(-20.74%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 13.77 Million USD | -43.09% |
2022 | 24.19 Million USD | -17.94% |
2021 | 29.48 Million USD | -11.18% |
2020 | 33.19 Million USD | 39.33% |
2019 | 23.82 Million USD | 0.53% |
2018 | 23.69 Million USD | 57.07% |
2017 | 15.08 Million USD | -71.83% |
2016 | 53.55 Million USD | -1.01% |
2015 | 54.1 Million USD | 118.34% |
2014 | 24.78 Million USD | -0.91% |
2013 | 25 Million USD | -17.53% |
2012 | 30.32 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 17.29 Million USD | 2.58% |
2024 Q1 | 16.86 Million USD | 22.44% |
2023 Q2 | 16.94 Million USD | -17.23% |
2023 FY | 13.77 Million USD | -43.09% |
2023 Q1 | 20.47 Million USD | -15.4% |
2023 Q4 | 13.77 Million USD | -22.83% |
2023 Q3 | 17.84 Million USD | 5.32% |
2022 Q4 | 24.19 Million USD | -13.44% |
2022 Q3 | 27.95 Million USD | 2.88% |
2022 FY | 24.19 Million USD | -17.94% |
2022 Q1 | 31.61 Million USD | 7.21% |
2022 Q2 | 27.16 Million USD | -14.06% |
2021 Q2 | 38.18 Million USD | -9.31% |
2021 Q3 | 33.73 Million USD | -11.66% |
2021 Q4 | 29.48 Million USD | -12.61% |
2021 FY | 29.48 Million USD | -11.18% |
2021 Q1 | 42.1 Million USD | 26.85% |
2020 Q1 | 22.8 Million USD | -4.3% |
2020 Q4 | 33.19 Million USD | -10.15% |
2020 Q3 | 36.94 Million USD | 27.91% |
2020 FY | 33.19 Million USD | 39.33% |
2020 Q2 | 28.88 Million USD | 26.68% |
2019 Q1 | 26.25 Million USD | 10.78% |
2019 Q2 | 28.81 Million USD | 9.77% |
2019 Q4 | 23.82 Million USD | -14.93% |
2019 Q3 | 28 Million USD | -2.82% |
2019 FY | 23.82 Million USD | 0.53% |
2018 Q1 | 23.96 Million USD | 58.82% |
2018 FY | 23.69 Million USD | 57.07% |
2018 Q4 | 23.69 Million USD | 29.52% |
2018 Q3 | 18.29 Million USD | -4.85% |
2018 Q2 | 19.23 Million USD | -19.75% |
2017 Q3 | 20.97 Million USD | -23.44% |
2017 FY | 15.08 Million USD | -71.83% |
2017 Q4 | 15.08 Million USD | -28.05% |
2017 Q2 | 27.39 Million USD | -30.16% |
2017 Q1 | 39.22 Million USD | -26.77% |
2016 Q1 | 42.16 Million USD | -22.06% |
2016 Q3 | 60.43 Million USD | 58.25% |
2016 Q2 | 38.19 Million USD | -9.43% |
2016 Q4 | 53.55 Million USD | -11.39% |
2016 FY | 53.55 Million USD | -1.01% |
2015 FY | 54.1 Million USD | 118.34% |
2015 Q1 | 79.89 Million USD | 222.41% |
2015 Q2 | 70.56 Million USD | -11.68% |
2015 Q4 | 54.1 Million USD | -14.76% |
2015 Q3 | 63.47 Million USD | -10.05% |
2014 Q2 | 16.23 Million USD | 0.0% |
2014 FY | 24.78 Million USD | -0.91% |
2014 Q4 | 24.78 Million USD | 7.44% |
2014 Q1 | - USD | -100.0% |
2014 Q3 | 23.06 Million USD | 42.07% |
2013 FY | 25 Million USD | -17.53% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | 25 Million USD | 0.0% |
2012 FY | 30.32 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Akoya Biosciences, Inc. | 180.36 Million USD | 92.366% |
AngioDynamics, Inc. | 317.67 Million USD | 95.665% |
AtriCure, Inc. | 613.93 Million USD | 97.757% |
Azenta, Inc. | 2.88 Billion USD | 99.523% |
BioLife Solutions, Inc. | 412.71 Million USD | 96.664% |
The Cooper Companies, Inc. | 11.65 Billion USD | 99.882% |
Daxor Corporation | 34.86 Million USD | 60.509% |
Ekso Bionics Holdings, Inc. | 28.91 Million USD | 52.383% |
Femasys Inc. | 27.75 Million USD | 50.389% |
GlucoTrack, Inc. | 4.9 Million USD | -180.734% |
Harvard Bioscience, Inc. | 137.36 Million USD | 89.976% |
Hologic, Inc. | 9.15 Billion USD | 99.85% |
ICU Medical, Inc. | 4.37 Billion USD | 99.686% |
Intuitive Surgical, Inc. | 15.44 Billion USD | 99.911% |
KORU Medical Systems, Inc. | 28.46 Million USD | 51.618% |
LeMaitre Vascular, Inc. | 346.77 Million USD | 96.029% |
Innovative Eyewear, Inc. | 6.21 Million USD | -121.427% |
Innovative Eyewear, Inc. | 6.21 Million USD | -121.427% |
Masimo Corporation | 3.04 Billion USD | 99.547% |
Microbot Medical Inc. | 8.32 Million USD | -65.366% |
Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 91.99% |
Merit Medical Systems, Inc. | 2.32 Billion USD | 99.408% |
Nephros, Inc. | 11.86 Million USD | -16.095% |
NovoCure Limited | 1.14 Billion USD | 98.799% |
NEXGEL, Inc. | 9.95 Million USD | -38.322% |
NEXGEL, Inc. | 9.95 Million USD | -38.322% |
Singular Genomics Systems, Inc. | 265.46 Million USD | 94.813% |
OraSure Technologies, Inc. | 482.84 Million USD | 97.148% |
Pro-Dex, Inc. | 54.21 Million USD | 74.599% |
Pulse Biosciences, Inc. | 60.8 Million USD | 77.353% |
Predictive Oncology Inc. | 14.41 Million USD | 4.489% |
Precision Optics Corporation, Inc. | 16.91 Million USD | 18.581% |
QuidelOrtho Corporation | 8.56 Billion USD | 99.839% |
Repligen Corporation | 2.82 Billion USD | 99.512% |
Sanara MedTech Inc. | 73.87 Million USD | 81.359% |
STAAR Surgical Company | 488.69 Million USD | 97.182% |
Sharps Technology, Inc. | 11.78 Million USD | -16.801% |
Utah Medical Products, Inc. | 135.45 Million USD | 89.834% |
DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.813% |
Jin Medical International Ltd. | 32.9 Million USD | 58.15% |